K

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Director, Program Management

Program ManagementConfirmed live in the last 24 hours
Full-timeLexington, MA, USA$201k - $239k

About the Job

Requirements

  • At least 10 years of biotechnology or pharmaceutical drug-development experience, including substantial experience in clinical-stage development.
  • At least 5 years in program management, program leadership, clinical operations, or a closely related cross-functional development role.
  • Demonstrated experience supporting or leading clinical programs across Phase 1, Phase 2, and Phase 3.
  • Strong understanding of end-to-end drug development and the interdependencies among clinical, regulatory, CMC, biometrics, nonclinical, and commercial activities.
  • Demonstrated ability to lead complex cross-functional teams and influence at all levels of an organization.
  • Experience applying program-management principles and practices to integrated development plans, timelines, dependencies, risks, decisions, budgets, and resources.
  • Must be located in the Boston area or willing to relocate and able to work from the office four days per week.
  • Ability to travel up to 10%, including domestic and international travel.
  • Bachelor's degree in a scientific, medical, engineering, or related discipline.

Responsibilities

  • Serve as the program management lead for rinvatercept, partnering with functional leaders to define and execute the optimal global development strategy.
  • Lead the cross-functional program team, including representatives from Clinical Development, Clinical Operations, Regulatory Affairs, CMC/Technical Operations, Nonclinical, Biometrics, Medical Affairs, Commercial, and Corporate Strategy.
  • Guide the program through proof of concept, registration-enabling studies, regulatory submissions, and potential marketing authorization.
  • Translate development strategy into clear program objectives, operational priorities, and measurable deliverables.
  • Mobilize and align the organization around the program strategy and drive timely decision-making through appropriate governance forums.
  • Balance day-to-day program execution with long-range strategic planning.
  • Create and maintain an integrated strategic development plan covering program goals, value-creation milestones, critical-path activities, cross-functional dependencies, timelines, decision points, assumptions, risks, alternative scenarios, budget, and resource requirements.
  • Ensure functional plans are aligned with the overall development strategy and that interdependencies are clearly understood and actively managed.
  • Identify potential gaps, conflicts, and constraints before they affect clinical, regulatory, or operational milestones.
  • Lead scenario planning to evaluate alternative development approaches and their implications for timeline, resources, risk, and program value.
  • Partner with Clinical Development and Clinical Operations to plan and execute rinvatercept clinical trials across Phase 1, Phase 2, and Phase 3.
  • Integrate clinical activities with regulatory, CMC, nonclinical, biometrics, and other program workstreams.
  • Identify and manage dependencies affecting protocol development, regulatory submissions, site activation, patient enrollment, study conduct, data delivery, and clinical readouts.
  • Support transitions between stages of development, including progression from early clinical studies into proof-of-concept and registration-enabling trials.
  • Apply an understanding of neuromuscular and rare-disease trial challenges, including specialized investigator sites, patient recruitment, natural-history considerations, endpoints, and global execution.
  • Ensure clinical-trial plans are supported by realistic timelines, budgets, resources, and risk-mitigation plans.
  • Establish and lead an effective operating cadence for program team meetings, working sessions, and governance reviews.
  • Prepare agendas, facilitate discussions, and ensure decisions, action items, owners, and deadlines are clearly documented and communicated.
  • Foster strong relationships with program team members and functional line leaders, and serve as a central point of contact for program communications and issue resolution.
  • Create clarity around roles, responsibilities, and decision rights to enable efficient execution and accountability.
  • Promote a program culture characterized by urgency, transparency, scientific rigor, collaboration, and respect.
  • Represent the rinvatercept program team at internal governance meetings, in collaboration with relevant team members.
  • Develop high-quality program updates, recommendations, and decision materials for senior management and governance committees.
  • Present program strategy, operating plans, progress, risks, and alternative scenarios clearly and persuasively.
  • Ensure governance decisions are documented and translated into executable cross-functional plans.
  • Proactively escalate issues requiring senior-management attention and provide clear options and recommendations.
  • Maintain a decision log capturing major decisions, assumptions, rationale, and implications.
  • Establish and maintain an integrated risk register covering clinical, regulatory, CMC, nonclinical, operational, financial, and strategic risks.
  • Work with functional leaders to define mitigation plans, contingency actions, owners, and escalation thresholds.
  • Proactively identify emerging issues that could affect program timelines, clinical execution, regulatory strategy, or key value-creation milestones.
  • Facilitate timely resolution of cross-functional issues and ensure agreed mitigation actions are completed.
  • Communicate program strategy, operating plans, progress, and risks effectively to senior management.
  • Represent the program team in scientific and business discussions, conveying complex information concisely and in a decision-oriented manner.
  • As appropriate, represent rinvatercept and Keros in interactions with investigators, scientific experts, development partners, patient-advocacy organizations, and other external stakeholders.
  • Partner with Clinical Development, Medical Affairs, and other functions to incorporate relevant external perspectives into program planning.
  • Coordinate program budgets, forecasts, and resource assumptions with Finance and functional leaders.
  • Monitor execution against approved timelines, budgets, and resource plans.
  • Identify resource constraints and capacity risks early and work with functional leadership to develop practical solutions.
  • Support vendor and external-partner planning where activities span multiple program functions.
  • Establish and continuously improve fit-for-purpose program-management processes, tools, reporting practices, and documentation.

Desired Qualifications

  • Advanced degree.

About the Company

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Keros Therapeutics focuses on developing therapies that target the transforming growth factor-beta (TGF-ß) signaling pathway to treat diseases linked to its dysfunction. Its products aim to modulate TGF-ß signaling to influence cellular growth and repair, with the goal of altering disease progression and providing disease-modifying benefits, especially in blood cells and tissues. The company advances therapeutics through research and development, with commercialization as its end goal once therapies are approved for patients. What sets Keros apart is its specialized expertise in TGF-ß biology and its emphasis on creating drugs that directly modulate this signaling network to produce meaningful clinical outcomes. The overall goal is to bring therapies to market that improve patient outcomes by correcting or adjusting TGF-ß-related signaling in relevant diseases.

Company size
51-200
Company stage
IPO
Headquarters
Lexington, KY
Founded
2015

Recently Posted Jobs

Explore more opportunities at Keros Therapeutics

See more jobs